Sierra Oncology

About:

Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.

Website: http://sierraoncology.com

Twitter/X: sierraoncology

Top Investors: OrbiMed, RA Capital Management, Michigan Economic Development Corporation, Frazier Healthcare Partners, Vivo Capital

Description:

Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease. Sierra Oncology's team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.

Total Funding Amount:

$494M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Mateo, California, United States

Founded Date:

2004-01-01

Contact Email:

investors(AT)sierraoncology.com

Founders:

Mina Patel Sooch, Robert Forgey

Number of Employees:

101-250

Last Funding Date:

2022-01-31

IPO Status:

Public

© 2025 bioDAO.ai